FDA
-
‘No indication’ U.S. blueberry recall for death risk impacts Canada: CFIAA Class 1 FDA recall is when 'there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.'CanadaAug 21
-
U.S. FDA approves new breast cancer drug that could slow disease significantlyRevtorpyk is intended to treat patients with advanced breast cancer whose tumors have low levels of a protein called HER2 and no mutation in a gene called PIK3CA.HealthJul 14
-
U.S. FDA approves Eli Lilly’s GLP-1 oral weight-loss pillThe U.S. FDA said the drug was approved within 50 days of the company filing for approval, one of the fastest approval times for any drug.HealthApr 1
![]()
-
FDA approves another abortion pill, sparks conservative backlashThe FDA approved the original version of mifepristone in 2000 and gradually eased access over time.U.S. NewsOct 3, 2025
![]()
-
Infant formula is under health review in the U.S. What parents should knowThe effort launched by U.S. Health Secretary Robert F. Kennedy Jr., dubbed “Operation Stork Speed," is the first deep look at the ingredients in formula since 1998.HealthJun 3, 2025
![]()
-
Some acne products recalled in U.S. due to benzene, ‘no impact’ in CanadaThe Food and Drug Administration said several lots of six products containing benzoyl peroxide are being recalled, though it stressed consumers faced little risk.HealthMar 14, 2025
![]()
-
FDA cancels meeting on selecting strains for next season’s flu shotA meeting of a committee which advises the U.S. Food and Drug Administration on vaccine policy has been canceled, a committee member told Reuters.HealthFeb 27, 2025
![]()
-
Ozempic, Wegovy shortages are resolved in the U.S.: FDAThe drugmaker Novo Nordisk can meet present and future demand in the U.S. for its drugs including Ozempic and Wegovy, the U.S. Food and Drug Administration said.HealthFeb 21, 2025
![]()
-
The FDA wants these cold medicines off the shelves. Should Canada follow?The FDA has proposed removing phenylephrine, a common ingredient in decongestants, due to its ineffectiveness, which may prompt Canada to review its approval of the drug.HealthNov 14, 2024
![]()
-
FDA launches probe after study finds trace toxic metals in tampon brandsThe U.S. FDA has launched an investigation into the safety of tampons following a study that found trace amounts of toxic metals, such as arsenic and lead, in various brands.ConsumerSep 11, 2024
![]()
